Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Artificial intelligence-driven clinical decision support systems to assist healthcare professionals and people with diabetes in Europe at the point of care: a Delphi-based consensus roadmap
0
Zitationen
19
Autoren
2025
Jahr
Abstract
The use of artificial intelligence (AI) to improve the diagnosis, assessment and treatment of people with diabetes has the potential to drive a paradigm shift in diabetes care, both minimising treatment inertia and optimising clinical outcomes. This is a significant opportunity, given the predicted increase in the burden of diabetes over the next 20 years. However, there are concerns that regulatory processes for development and implementation of AI-driven technologies are not adequate for systems that may adapt to new data and change from their original performance characteristics as evaluated. The European Diabetes Forum (EUDF) convened a working group to review and investigate the unmet needs around implementation of AI technology in diabetes care. The working group developed the framework and focus of the accompanying analysis through a series of virtual and face-to-face meetings, including email conversations. The working group examined the key objectives for good diabetes care in the context of current and predicted AI-driven clinical decision support systems (AI-CDSS), including the outcomes for people with diabetes, the goals for personalised medicine and the implications for guideline-driven diabetes services and healthcare professionals. The process covered the needs of primary care healthcare professionals, who will shoulder the majority of diabetes care. The challenge of developing regulatory concepts and processes that are sufficiently robust to be AI inclusive was considered as central to the outcomes. Based on the available evidence, the EUDF working group believes that AI-CDSS will deliver benefits for people with diabetes, although there are clear challenges to moving AI-CDSS into the practical clinical space. To encourage debate on how this can be achieved safely and effectively, at the conclusion of the process a series of 14 recommendations was agreed using a nominal group technique and Delphi methodology, which are discussed in context in this article.
Ähnliche Arbeiten
Explainable Artificial Intelligence (XAI): Concepts, taxonomies, opportunities and challenges toward responsible AI
2019 · 8.200 Zit.
Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead
2019 · 8.051 Zit.
High-performance medicine: the convergence of human and artificial intelligence
2018 · 7.416 Zit.
Proceedings of the 19th International Joint Conference on Artificial Intelligence
2005 · 5.776 Zit.
Peeking Inside the Black-Box: A Survey on Explainable Artificial Intelligence (XAI)
2018 · 5.410 Zit.
Autoren
Institutionen
- University of Split(HR)
- Ljubljana University Medical Centre(SI)
- Instituto de Salud Carlos III(ES)
- Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas(ES)
- Institut Català de la Salut(ES)
- King's College - North Carolina(US)
- King's College London(GB)
- Sanofi (France)(FR)
- Florence Nightingale Foundation(GB)
- Yale University(US)
- Guy's and St Thomas' NHS Foundation Trust(GB)
- Kings Health Partners(GB)
- Novo Nordisk (Denmark)(DK)
- Université de Caen Normandie(FR)
- Diabetes Australia(AU)
- University of Belgrade(RS)
- Center for Health, Exercise and Sport Sciences(RS)
- University Clinical Centre(PL)
- Tel Aviv University(IL)
- Schneider Children's Medical Center(IL)
- Deutsches Diabetes-Zentrum e.V.(DE)
- German Center for Diabetes Research(DE)
- University Hospital Carl Gustav Carus(DE)
- Paul Langerhans Institute Dresden(DE)
- Heinrich Heine University Düsseldorf(DE)
- University of Edinburgh(GB)
- Médecins Sans Frontières(CH)
- Scuola Superiore Sant'Anna(IT)